These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 4456737

  • 1. Impaired elimination of meperidine in patients with liver disease.
    McHorse TS, Klotz U, Wilkinson G, Schenker S.
    Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
    [No Abstract] [Full Text] [Related]

  • 2. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA, Cain GD, Dickinson G.
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract] [Full Text] [Related]

  • 3. The prognostic value of laboratory tests in liver disease.
    Tygstrup N.
    Scand J Gastroenterol Suppl; 1973 Apr; 19():47-50. PubMed ID: 4123936
    [No Abstract] [Full Text] [Related]

  • 4. Cholic acid clearance in normal subjects and in patients with liver disease.
    Borel GA, Lemp R, Diallo T, Magnenat P.
    Helv Med Acta; 1973 Sep; 37(2):201-7. PubMed ID: 4748930
    [No Abstract] [Full Text] [Related]

  • 5. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J, McHorse T, Hoyumpa A, Bush MT, Schenker S.
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [Abstract] [Full Text] [Related]

  • 6. Effect of acute viral hepatitis in man on the disposition and elimination of meperidine.
    McHorse TS, Wilkinson GR, Johnson RF, Schenker S.
    Gastroenterology; 1975 Apr; 68(4 Pt 1):775-80. PubMed ID: 235484
    [No Abstract] [Full Text] [Related]

  • 7. [Diagnostic significance of serum -glucuronidase. 3. Behavior of serum -glucuronidase activity in liver diseases in comparison to other clinical and chemical study results].
    Nilius R.
    Z Gesamte Inn Med; 1971 Jun 15; 26(12):384-93. PubMed ID: 5122587
    [No Abstract] [Full Text] [Related]

  • 8. The behaviour of ceruloplasmin fractions in liver diseases.
    Trip JA, Que GS, Botterweg-Span Y, Mandema E.
    Acta Med Scand; 1969 Apr 15; 185(4):279-86. PubMed ID: 5806337
    [No Abstract] [Full Text] [Related]

  • 9. Clinical findings in patients with hepatitis and abnormal bile duct epithelium.
    Christoffersen P, Poulsen H, Winkler K.
    Scand J Gastroenterol; 1970 Apr 15; 5(2):117-21. PubMed ID: 5429872
    [No Abstract] [Full Text] [Related]

  • 10. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA, Braconier JH, Eriksson O.
    Scand J Gastroenterol Suppl; 1973 Apr 15; 19():83-91. PubMed ID: 4515643
    [No Abstract] [Full Text] [Related]

  • 11. [Serum adenosine deaminase in acute viral hepatitis and chronic liver diseases].
    Nilius R, Zipprich B.
    Z Gesamte Inn Med; 1973 Feb 15; 28(4):101-5. PubMed ID: 4701002
    [No Abstract] [Full Text] [Related]

  • 12. Discriminant analysis of biochemical parameters in liver disease.
    Olubuyide IO, Festing MF, Chapman C, Higginson J, Whicher JT.
    Trop Gastroenterol; 1997 Feb 15; 18(1):15-9. PubMed ID: 9197166
    [Abstract] [Full Text] [Related]

  • 13. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT, Marigold JH, Thompson RP.
    Hepatogastroenterology; 1982 Apr 15; 29(2):55-7. PubMed ID: 7084884
    [Abstract] [Full Text] [Related]

  • 14. The effect of cirrhosis on the disposition and elimination of meperidine in man.
    Klotz U, McHorse TS, Wilkinson GR, Schenker S.
    Clin Pharmacol Ther; 1974 Oct 15; 16(4):667-75. PubMed ID: 4419525
    [No Abstract] [Full Text] [Related]

  • 15. Tyrosine metabolism in patients with liver disease.
    Levine RJ, Conn HO.
    J Clin Invest; 1967 Dec 15; 46(12):2012-20. PubMed ID: 6074004
    [Abstract] [Full Text] [Related]

  • 16. Impairment of drug elimination in patients with liver disease.
    Narang AP, Datta DV, Mathur VS.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan 15; 23(1):28-32. PubMed ID: 3988389
    [Abstract] [Full Text] [Related]

  • 17. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
    Custro N, De Francisci MC, Patanella I, Scafidi V, Indovina I.
    Minerva Med; 1984 Nov 03; 75(42):2527-32. PubMed ID: 6083507
    [Abstract] [Full Text] [Related]

  • 18. Multiphasic testing for liver-related abnormalities in hemorrhoidal disease.
    Ganchrow MI, Bowman HE.
    Surg Gynecol Obstet; 1971 Mar 03; 132(3):478-82. PubMed ID: 5546301
    [No Abstract] [Full Text] [Related]

  • 19. [Level of total protein-bound hexoses in the blood serum and their excretion in the urine of patients with acute viral hepatitis (Botkin's disease)].
    Fedianin IuP, Rabinovich PD, Vaĭstukh SI.
    Ter Arkh; 1974 Mar 03; 46(4):63-7. PubMed ID: 4428369
    [No Abstract] [Full Text] [Related]

  • 20. Indocyanine green clearance in critically ill patients.
    Pollack DS, Sufian S, Matsumoto T.
    Surg Gynecol Obstet; 1979 Dec 03; 149(6):852-4. PubMed ID: 388703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.